We demonstrate that Six1 is overexpressed in the CD24low/CD44+ TIC population from human luminal breast cancers, and that it can induce TICs when overexpressed in luminal breast cancer cells via its ability to activate both TGF-β and ERK signaling. The gene discussed is CD44; the disease is breast carcinoma.